Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 2867747!ä!2867747 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Intern+Med 1986 ; 146 (1): 129-33 Nephropedia Template TP {{tp|p=2867747|t=1986. Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease |pdf=|usr=}}{{2867747}} gab.com Text Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease JO: Arch Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=2867747 #FOAvip When a patient with chronic obstructive pulmonary disease (COPD) requires medical therapy for systemic hypertension, a number of special considerations may affect the choice of antihypertensive drug and subsequent management. Thiazide diuretics have no adverse effect on airway function and are the agents of choice for initial therapy. beta-Antagonists are usually considered first-line agents in antihypertensive therapy, but even relatively cardioselective ones may increase airway resistance in patients with obstructive lung diseases, and they should be used with caution, if at all, in such patients. Although potassium-wasting diuretics are the preferred agents for treating hypertension in patients with COPD, they may worsen carbon dioxide retention in hypoventilating patients and potentiate hypokalemia in those receiving corticosteroids. In addition, beta-agonists may substantially lower serum potassium levels in patients already rendered hypokalemic by diuretics. Patients with COPD receiving potassium-wasting diuretics who have chronic respiratory acidosis or are receiving corticosteroids or beta-agonists should undergo close monitoring of electrolyte levels and be considered for therapy with potassium supplements or, preferably, potassium-sparing agents. Twit Text FOAVip Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease ????Arch Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=2867747 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=2867747 #FOAvip English Wikipedia <ref>{{Cite pmid|2867747}}</ref> Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease #MMPMID2867747 Hill NS Arch Intern Med 1986[Jan]; 146 (1): 129-33 PMID2867747show ga When a patient with chronic obstructive pulmonary disease (COPD) requires medical therapy for systemic hypertension, a number of special considerations may affect the choice of antihypertensive drug and subsequent management. Thiazide diuretics have no adverse effect on airway function and are the agents of choice for initial therapy. beta-Antagonists are usually considered first-line agents in antihypertensive therapy, but even relatively cardioselective ones may increase airway resistance in patients with obstructive lung diseases, and they should be used with caution, if at all, in such patients. Although potassium-wasting diuretics are the preferred agents for treating hypertension in patients with COPD, they may worsen carbon dioxide retention in hypoventilating patients and potentiate hypokalemia in those receiving corticosteroids. In addition, beta-agonists may substantially lower serum potassium levels in patients already rendered hypokalemic by diuretics. Patients with COPD receiving potassium-wasting diuretics who have chronic respiratory acidosis or are receiving corticosteroids or beta-agonists should undergo close monitoring of electrolyte levels and be considered for therapy with potassium supplements or, preferably, potassium-sparing agents. |Adrenal Cortex Hormones/adverse effects[MESH] |Adrenergic beta-Agonists/adverse effects[MESH] |Adrenergic beta-Antagonists/therapeutic use[MESH] |Benzothiadiazines[MESH] |Calcium Channel Blockers/therapeutic use[MESH] |Diuretics/*adverse effects[MESH] |Drug Interactions[MESH] |Humans[MESH] |Hypertension/complications/*drug therapy/physiopathology[MESH] |Hypokalemia/chemically induced/drug therapy[MESH] |Lung Diseases, Obstructive/*complications[MESH] |Magnesium Deficiency/chemically induced[MESH] |Potassium/therapeutic use[MESH] |Pulmonary Gas Exchange/drug effects[MESH] |Sodium Chloride Symporter Inhibitors/adverse effects[MESH]Fluid and electrolyte considerations in diuretic therapy for hypertens(epmc).pdf DeepDyve Pubget Overpricing